111 related articles for article (PubMed ID: 16905296)
1. Effect of pulverization and dehydration on the pharmaceutical properties of calcium lactate pentahydrate tablets.
Sakata Y; Shiraishi S; Takayama K; Otsuka M
Colloids Surf B Biointerfaces; 2006 Aug; 51(2):149-56. PubMed ID: 16905296
[TBL] [Abstract][Full Text] [Related]
2. Effect of pulverization of the bulk powder on the hydration of creatine anhydrate tablets and their pharmaceutical properties.
Sakata Y; Shiraishi S; Otsuka M
Colloids Surf B Biointerfaces; 2005 Dec; 46(2):92-100. PubMed ID: 16274970
[TBL] [Abstract][Full Text] [Related]
3. Effect of tablet geometrical structure on the dehydration of creatine monohydrate tablets, and their pharmaceutical properties.
Sakata Y; Shiraishi S; Otsuka M
AAPS PharmSciTech; 2005 Oct; 6(3):E527-35. PubMed ID: 16354014
[TBL] [Abstract][Full Text] [Related]
4. Characterization of dehydration and hydration behavior of calcium lactate pentahydrate and its anhydrate.
Sakata Y; Shiraishi S; Otsuka M
Colloids Surf B Biointerfaces; 2005 Dec; 46(3):135-41. PubMed ID: 16293401
[TBL] [Abstract][Full Text] [Related]
5. A novel white film for pharmaceutical coating formed by interaction of calcium lactate pentahydrate with hydroxypropyl methylcellulose.
Sakata Y; Shiraishi S; Otsuka M
Int J Pharm; 2006 Jul; 317(2):120-6. PubMed ID: 16621357
[TBL] [Abstract][Full Text] [Related]
6. Effect of pulverization on hydration kinetic behaviors of creatine anhydrate powders.
Sakata Y; Shiraishi S; Otsuka M
Colloids Surf B Biointerfaces; 2004 Dec; 39(4):187-93. PubMed ID: 15555902
[TBL] [Abstract][Full Text] [Related]
7. Characterization of dehydration behavior of untreated and pulverized creatine monohydrate powders.
Sakata Y; Shiraishi S; Otsuka M
Colloids Surf B Biointerfaces; 2004 Jun; 35(3-4):185-91. PubMed ID: 15261030
[TBL] [Abstract][Full Text] [Related]
8. Investigating the effect of dehydration conditions on the compactability of glucose.
Trasi NS; Boerrigter SX; Byrn SR; Carvajal TM
Int J Pharm; 2011 Mar; 406(1-2):55-61. PubMed ID: 21232587
[TBL] [Abstract][Full Text] [Related]
9. Crystal growth formation in melt extrudates.
Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
[TBL] [Abstract][Full Text] [Related]
10. Powder X-ray diffraction can differentiate between enantiomeric variants of calcium lactate pentahydrate crystal in cheese.
Tansman GF; Kindstedt PS; Hughes JM
J Dairy Sci; 2014 Dec; 97(12):7354-62. PubMed ID: 25459903
[TBL] [Abstract][Full Text] [Related]
11. Nano- and macro-geometrical structural change of caffeine and theophylline anhydrate tablets during hydration process by using X-ray computed tomography.
Otsuka M; Ibe K; Tokudome Y; Ohshima H
Colloids Surf B Biointerfaces; 2009 Oct; 73(2):351-9. PubMed ID: 19559580
[TBL] [Abstract][Full Text] [Related]
12. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
Sauer D; Zheng W; Coots LB; McGinity JW
Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
[TBL] [Abstract][Full Text] [Related]
13. Improvement of physicomechanical properties of carbamazepine by recrystallization at different pH values.
Javadzadeh Y; Mohammadi A; Khoei NS; Nokhodchi A
Acta Pharm; 2009 Jun; 59(2):187-97. PubMed ID: 19564143
[TBL] [Abstract][Full Text] [Related]
14. Effects of disintegration-promoting agent, lubricants and moisture treatment on optimized fast disintegrating tablets.
Late SG; Yu YY; Banga AK
Int J Pharm; 2009 Jan; 365(1-2):4-11. PubMed ID: 18778759
[TBL] [Abstract][Full Text] [Related]
15. Influence of environmental conditions on the kinetics and mechanism of dehydration of carbamazepine dihydrate.
Han J; Suryanarayanan R
Pharm Dev Technol; 1998 Nov; 3(4):587-96. PubMed ID: 9834963
[TBL] [Abstract][Full Text] [Related]
16. Liquisolid technique as a new approach to sustain propranolol hydrochloride release from tablet matrices.
Javadzadeh Y; Musaalrezaei L; Nokhodchi A
Int J Pharm; 2008 Oct; 362(1-2):102-8. PubMed ID: 18647643
[TBL] [Abstract][Full Text] [Related]
17. DC calcium lactate, a new filler-binder for direct compaction of tablets.
Bolhuis GK; Eissens AC; Zoestbergen E
Int J Pharm; 2001 Jun; 221(1-2):77-86. PubMed ID: 11397569
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of telmisartan tablets prepared via the wet granulation method and pritor™ prepared using the spray-drying method.
Park J; Park HJ; Cho W; Cha KH; Yeon W; Kim MS; Kim JS; Hwang SJ
Arch Pharm Res; 2011 Mar; 34(3):463-8. PubMed ID: 21547679
[TBL] [Abstract][Full Text] [Related]
19. Influence of shear intensity and total shear on properties of blends and tablets of lactose and cellulose lubricated with magnesium stearate.
Mehrotra A; Llusa M; Faqih A; Levin M; Muzzio FJ
Int J Pharm; 2007 May; 336(2):284-91. PubMed ID: 17236729
[TBL] [Abstract][Full Text] [Related]
20. A Holistic Multi Evidence Approach to Study the Fragmentation Behaviour of Crystalline Mannitol.
Koner JS; Rajabi-Siahboomi A; Bowen J; Perrie Y; Kirby D; Mohammed AR
Sci Rep; 2015 Nov; 5():16352. PubMed ID: 26553127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
